Lupus Erythematosus, Discoid - 22 Studies Found
Completed |
: A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies : Lupus Erythematosus, Discoid : 2012-12-19 :
|
Completed |
: Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients : Discoid Lupus Erythematosus : 2008-07-01 : Drug: CC-10004 20 mg twice daily by mouth for 12 weeks, followed by a 4 week washout period and final as |
Completed |
: Cutaneous Lupus Erythematosus and Elidel :
: Drug: Elidel (pimecrolimus) |
Terminated |
: Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus :
: |
Completed |
: To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus : Cutaneous Lupus Erythematosus : 2010-10-18 :
|
Completed |
: A Non-drug Study Profiling Cutaneous Lupus :
|
Active, not recruiting |
: Autologous Polyclonal Tregs for Lupus :
: Biological: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells Other Name: Ex vivo Expanded |
Completed |
: A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers :
|
Completed |
: Pilot Tape Harvesting Study :
|
Completed |
: Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia :
|